To explore the safety and effectiveness of dual-target CAR T-cells in the treatment of PCNS-DLBCL, we conducted a clinical trial utilizing 4SCAR T-cells specifically targeting against both CD19 (4SCAR19) and CD70 (4SCAR70). The gene discussed is CD70; the disease is diffuse large B-cell lymphoma.